← Back to Search

Hypertension Canada Professional Certification Program: HC-PCP for High Blood Pressure

N/A
Waitlist Available
Led By Ross Tsuyuki, PharmD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with poorly controlled blood pressure (>140/90mmHg or >130/80mmHg if they have diabetes).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months following follow up
Awards & highlights

Study Summary

This trial will study whether a hypertension management certification program for community pharmacists can help lower blood pressure in patients.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months following follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months following follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The difference in change in systolic blood pressure between Intervention and Control patients.
Secondary outcome measures
Consultant Satisfaction Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention pharmacistsExperimental Treatment1 Intervention
Will receive the HC-PCP prior to starting enrollment, and then will provide care to their patients, which will include risk assessment, prescribing of antihypertensive medications, and follow-up monthly according to the Hypertension Canada Guidelines.
Group II: Control pharmacistsActive Control1 Intervention
Will provide usual pharmacist care. All patients with blood pressure above target will be entered into the study database and serve as the control group. No specific interventions or follow-up will be mandated other than usual pharmacist care, although all patients will be assessed at 3 months to determine change in BP since enrollment (the primary outcome).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hypertension Canada Professional Certification Program: HC-PCP
2020
N/A
~890

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
883 Previous Clinical Trials
392,319 Total Patients Enrolled
Hypertension CanadaOTHER
1 Previous Clinical Trials
200 Total Patients Enrolled
Ross Tsuyuki, PharmDPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
368 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~198 spots leftby Mar 2025